| RS2149960307 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149961047 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149961425 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS2149961882 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149962117 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149964478 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149964888 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149964988 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2149965938 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149966329 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS2149969843 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149972499 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2149972605 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2149974011 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2149974329 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149976768 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149976879 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149978400 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149980503 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2149981074 |
COL4A4
|
Health Risk |
Likely pathogenic |
Benign familial hematuria, Benign familial hematuria |
| RS2149983785 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149984801 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149987292 |
APC
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149988984 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2149989087 |
CAMTA1
|
Health Risk |
Pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2149989620 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149989683 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149990101 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2149990719 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149992847 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149993330 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS2149993527 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2149995808 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS2149995957 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2149996574 |
APC
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2149996933 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2149997387 |
TBCK
|
Health Risk |
Pathogenic |
— |
| RS2149998986 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2150001373 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2150001671 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2150001892 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2150005919 |
TBCK
|
Health Risk |
Pathogenic |
— |
| RS2150010260 |
TBCK
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS2150010400 |
TBCK
|
Health Risk |
Likely pathogenic |
Hypotonia, infantile |
| RS2150010421 |
TBCK
|
Health Risk |
Pathogenic |
— |
| RS2150014852 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150016080 |
EYS
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2150016133 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150016153 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150016293 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS2150020225 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2150021992 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150022015 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS2150022025 |
EYS
|
Health Risk |
Likely pathogenic |
— |
| RS2150022701 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150022848 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150022860 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Cone-rod dystrophy |
| RS2150023851 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2150024332 |
CTNNA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS2150027394 |
MTO1
|
Health Risk |
Pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS2150029460 |
WDFY3
|
Health Risk |
Pathogenic |
-, - |
| RS2150031480 |
MTO1
|
Health Risk |
Pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS2150032416 |
CTNNA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2150034070 |
NEK1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS2150035785 |
MTO1
|
Health Risk |
Pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS2150042284 |
MTO1
|
Health Risk |
Pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS2150042308 |
MTO1
|
Health Risk |
Pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS2150042519 |
GDF9
|
Health Risk |
Likely pathogenic |
Premature ovarian failure 14, Premature ovarian failure 14 |
| RS2150044955 |
MTO1
|
Health Risk |
Pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS2150044996 |
MTO1
|
Health Risk |
Pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS2150047294 |
BLTP1
|
Health Risk |
Pathogenic |
Alkuraya-Kucinskas syndrome, Alkuraya-Kucinskas syndrome |
| RS2150050474 |
TBCK
|
Health Risk |
Pathogenic |
— |
| RS2150050727 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2150052710 |
DROSHA
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2150053706 |
TBCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypotonia, infantile |
| RS2150063115 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150063224 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS2150065330 |
CPLANE1
|
Health Risk |
Likely pathogenic |
— |
| RS2150065916 |
TBCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotonia, infantile |
| RS2150068111 |
TLR3
|
Health Risk |
risk factor |
Immunodeficiency 83, susceptibility to viral infections |
| RS2150071623 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150071769 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS2150071783 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150076741 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS2150076802 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150076826 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 25, Retinal dystrophy |
| RS2150076869 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS2150076878 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150076887 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS2150076935 |
EYS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2150079083 |
NEK1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS2150082239 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2150084747 |
LTBP1
|
Health Risk |
Pathogenic |
Cutis laxa, autosomal recessive |
| RS2150094107 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS2150096054 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS2150096130 |
EYS
|
Health Risk |
Likely pathogenic |
— |
| RS2150098305 |
AFF4
|
Health Risk |
Likely pathogenic |
Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome, Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome |
| RS2150098310 |
AFF4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome, Inborn genetic diseases |
| RS2150099218 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Salla disease |
| RS2150099225 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |